Trastuzumab Deruxtecan (T-Dxd) Combined with Local Therapy for Treatment of HR+/HER2+ Metastatic Breast Cancer with Liver and Distant Lymph Node Involvement: A Case Report
1. Abstract Breast cancer is the most prevalent cancer among women globally. Within breast cancer, the HR+/HER2+ subtype is particularly notable among luminal subtypes, as it shows resistance to both endocrine and anti-HER2 therapies. This …